Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma
NCT07802652Phase 2Not yet recruiting
- Sponsor
- Gustave Roussy
- Start
- Feb 2027
- Primary completion
- Nov 2031
- Countries
- 1
01
Overview
A Phase 2 trial of DT-7012 in undifferentiated pleomorphic sarcoma (UPS), dedifferentiated liposarcoma (DDL), sponsored by Gustave Roussy. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
DT-7012
03
Conditions
undifferentiated pleomorphic sarcoma (UPS)dedifferentiated liposarcoma (DDL)
Beyond the preview
Go deeper on NCT07802652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07802652.